Nascent Biotech Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.06 |
Market Cap |
$5.6 M |
Shares Outstanding |
32.17 M |
Public Float |
23.99 M |
Address |
601 21st Street Vero Beach Florida 32960 United States |
Employees | - |
Website | http://www.nascentbiotech.com |
Updated | 07/08/2019 |
Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which develops monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded in July 15, 2014 and is headquartered in Vero Beach, FL. |